Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Jun
27
2022
Three Considerations for Health Care Providers After the Dobbs Decision Foley & Lardner LLP
Jun
27
2022
JANAAC Recognized as an Accreditation Body Under FDA’s Accredited Third Party Certification Program Keller and Heckman LLP
Jun
24
2022
Senate Committee Holds Hearing on Implementation of TSCA Amendments Bergeson & Campbell, P.C.
Jun
24
2022
IRS Issues FAQs on Superfund Excise Tax on Certain Chemical Substances Bergeson & Campbell, P.C.
Jun
24
2022
Cattle Industry Urges Health Canada to Reconsider Front-of-Package Proposed Rule Keller and Heckman LLP
Jun
24
2022
Mid-Year Regulatory Update 2022: Pharmaceuticals in India Nishith Desai Associates
Jun
23
2022
U.S. Government Files Amicus Brief in Prop 12 Case Keller and Heckman LLP
Jun
23
2022
CMS Reduces COVID-19 Vaccine Mandate Surveys and Rescinds Surveyor Vaccination Requirements Epstein Becker & Green, P.C.
Jun
23
2022
Claim Construction and Jurisdictional Discovery Are More Than Skin Deep McDermott Will & Emery
Jun
23
2022
FDA Issues Untitled Letter to Althera Pharmaceuticals for Statements Relating to ROSZET® Sheppard, Mullin, Richter & Hampton LLP
Jun
23
2022
DOJ and FTC Virtual Workshop: Agencies Discuss Novel Approaches to Address Competition Issues in Pharmaceutical Mergers Mintz
Jun
22
2022
U.S. Supreme Court Refuses to Hear Medical Cannabis Workers’ Compensation Case Wilson Elser Moskowitz Edelman & Dicker LLP
Jun
22
2022
The Pendulum Swings Both Ways: State Responses to Protect Reproductive Health Data, Post-Roe Epstein Becker & Green, P.C.
Jun
22
2022
EPA follows the first rule of holes in its eighth attempt to determine the reach of the Clean Water Act Mintz
Jun
22
2022
US EPA Announces Drinking Water Health Advisories for Certain PFAS Chemicals Squire Patton Boggs (US) LLP
Jun
22
2022
The Weeds Thicken: Making Sense of the Ninth Circuit’s Decision Finding Delta-8 Legal Under Federal Law Bradley Arant Boult Cummings LLP
Jun
22
2022
A Truly Piscatory Exemption Allen Matkins Leck Gamble Mallory & Natsis LLP
Jun
22
2022
FDA Publishes Guidance on Oversight of Food Covered by SRAs Keller and Heckman LLP
Jun
21
2022
ACA Transparency in Coverage Disclosure Deadline for Health Plans Is Around the Corner. Are You (and Your Provider) Ready? Jones Walker LLP
Jun
21
2022
Cannabis Banking: Will the SAFE Banking Act Finally Pass? Bradley Arant Boult Cummings LLP
Jun
21
2022
Supreme Court Issues Decision Favorable to Hospitals on 340 B Payment Reduction: What to Do Next K&L Gates
Jun
21
2022
FDA Provides Updates on Closer to Zero Plan Keller and Heckman LLP
Jun
21
2022
Canada Publishes Draft Framework for the Risk Assessment of Manufactured Nanomaterials under CEPA Bergeson & Campbell, P.C.
Jun
21
2022
EPA Proposes New Rules Governing Section 401 Water Quality Certification K&L Gates
Jun
20
2022
Transgender Youth and Access to Healthcare Nelson Mullins
Jun
20
2022
Supreme Court Saves Hospitals from $1.6B Cut to 340B Program Sheppard, Mullin, Richter & Hampton LLP
Jun
17
2022
Pre-Employment Drug Testing Not Compensable Under California Law Holds Ninth Circuit Jackson Lewis P.C.
Jun
17
2022
“A Full Plate”: FTC’s Open Meeting on PBMs, AI, Privacy and Online Harms Proskauer Rose LLP
Jun
17
2022
Drug Development in the Metaverse ArentFox Schiff LLP
Jun
17
2022
HELP Committee Approves Bill to Address Infant Formula Shortage Keller and Heckman LLP
Jun
16
2022
FDA Responds to Severe Weather Incidents Keller and Heckman LLP
Jun
16
2022
Employer Need Not Reimburse Travel Expenses for Drug Test Proskauer Rose LLP
Jun
16
2022
SCOTUS Sides with 340B Hospitals and Denies CMS’s Attempt to Cut Reimbursement for 340B Drugs Polsinelli PC
Jun
16
2022
EPA’s New Drinking Water Health Advisories for PFAS Chemicals ArentFox Schiff LLP
Jun
16
2022
Wisconsin Legislative Committee will Allow PFAS Standards to Take Effect von Briesen & Roper, s.c.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins